Calcific Tendonitis Treatment: Barbotage vs. Barbotage With Cortisone Injection

  • End date
    Nov 19, 2022
  • participants needed
  • sponsor
    NYU Langone Health
Updated on 19 November 2021


The purpose of this study is to determine the efficacy of barbotage therapy by comparing the clinical and sonographic changes in patients that solely receive barbotage to patients receiving the standard of care, barbotage with cortisone injection.


Calcific tendonitis is a condition caused by calcium deposits building up in a person's muscles or tendons. If calcium builds up in an area, a person may feel pain and discomfort there. The purpose of this study is to determine the efficacy of barbotage therapy (injecting and washing the shoulder joint with saline) by comparing the amount of pain, shoulder function, and X-Rays in patients with calcific tendonitis that receive the standard of care, barbotage with cortisone injection, against barbotage with saline injection. Receiving barbotage without cortisone is therefore considered experimental.

Condition Calcific Tendinitis
Treatment Dexamethasone, Barbotage
Clinical Study IdentifierNCT04126278
SponsorNYU Langone Health
Last Modified on19 November 2021


Yes No Not Sure

Inclusion Criteria

Must be at least 18 years of age and younger than 90 years of age
Diagnosed with calcific tendonitis and ruled out other shoulder-related pathologies
Failed 1st line therapy (physical therapy and cortisone injection)
Intention to receive barbotage with cortisone as standard of care
or more months of shoulder pain
Finding of one or more calcifications 5 mm in size on either sonogram or radiograph, located on the supraspinatus tendon
Positive Hawkin's test or Neer's sign for impingement

Exclusion Criteria

Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
Osteoarthritis of the glenohumeral joint of the affected shoulder
Previous surgery or barbotage to the affected shoulder
History of prior allergic/hypersensitivity reactions related to the study medication
Shoulder instability, glenohumeral arthritis, AC pathology, inflammatory arthropathy, fibromyalgia, frozen shoulder or cervical radiculopathy
Sub-acromial injection with a corticosteroid or treatment by ESWT during the last 3 months before inclusion
Younger than 18 years of age or older than 90
Any patient considered a vulnerable subject
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note